Ensign Peak Advisors’s Avanos Medical AVNS Stock Holding History

Ensign Peak Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,289	Closed	-$116K	–	1726
2026 Q1	$116K	Hold	8,289	–	–	﹤0.01%	1528
2025 Q4	$93.1K	Sell	8,289 -15,600	-65%	-$178K	﹤0.01%	1587
2025 Q3	$276K	Hold	23,889	–	–	﹤0.01%	1591
2025 Q2	$292K	Hold	23,889	–	–	﹤0.01%	1657
2025 Q1	$342K	Hold	23,889	–	–	﹤0.01%	1626
2024 Q4	$380K	Hold	23,889	–	–	﹤0.01%	1654
2024 Q3	$574K	Hold	23,889	–	–	﹤0.01%	1569
2024 Q2	$476K	Hold	23,889	–	–	﹤0.01%	1617
2024 Q1	$476K	Sell	23,889 -1,205	-5%	-$23.3K	﹤0.01%	1633
2023 Q4	$563K	Buy	25,094 +2,100	+9%	+$43.4K	﹤0.01%	1636
2023 Q3	$465K	Hold	22,994	–	–	﹤0.01%	1613
2023 Q2	$588K	Hold	22,994	–	–	﹤0.01%	1585
2023 Q1	$684K	Buy	22,994 +1,500	+7%	+$43.5K	﹤0.01%	1527
2022 Q4	$582K	Buy	21,494 +550	+3%	+$13.4K	﹤0.01%	1570
2022 Q3	$456K	Hold	20,944	–	–	﹤0.01%	1504
2022 Q2	$573K	Hold	20,944	–	–	﹤0.01%	1396
2022 Q1	$702K	Hold	20,944	–	–	﹤0.01%	1402
2021 Q4	$726K	Sell	20,944 -20,510	-49%	-$663K	﹤0.01%	1441
2021 Q3	$1.29M	Hold	41,454	–	–	﹤0.01%	1325
2021 Q2	$1.51M	Hold	41,454	–	–	﹤0.01%	1269
2021 Q1	$1.81M	Hold	41,454	–	–	﹤0.01%	1161
2020 Q4	$1.9M	Hold	41,454	–	–	﹤0.01%	1094
2020 Q3	$1.38M	Hold	41,454	–	–	﹤0.01%	1169
2020 Q2	$1.22M	Hold	41,454	–	–	﹤0.01%	1210
2020 Q1	$1.12M	Hold	41,454	–	–	﹤0.01%	1120
2019 Q4	$1.4M	Buy	+41,454	New	+$1.5M	﹤0.01%	1206

Other funds holding AVNS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Ensign Peak Advisors's AVNS Position: Q2 2026 in Review

Ensign Peak Advisors sold out of Avanos Medical (AVNS) in Q2 2026, closing a stake of 8,289 shares — an estimated $116K sold.

Ensign Peak Advisors first reported a position in AVNS in Q4 2019 and held it in 26 quarters. The position peaked at $1.9M in Q4 2020. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

Ensign Peak Advisors reported no remaining Avanos Medical position as of Q2 2026 after selling out during the quarter.
Ensign Peak Advisors sold 8,289 Avanos Medical shares in Q2 2026, an estimated $116K.
Ensign Peak Advisors first reported a position in Avanos Medical in Q4 2019 and held it in 26 quarters.
Ensign Peak Advisors's Avanos Medical position peaked at $1.9M in Q4 2020.
286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.